Clinical trial
UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer
NCT00030888 · University of California, San Francisco, Other · Unknown status
Key facts
| NCT number | NCT00030888 |
|---|---|
| Title | UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer |
| Official title | A Phase 2 Study Of UCN-01 In Advanced Renal Cell Carcinoma |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Drug |
| Interventions | 7-hydroxystaurosporine |
| Start date | Dec 1, 2002 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: